Join
Live feed
·
PRReleasevia Quantisnow
Adverum Biotechnologies Inc. logo

Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program

ByQuantisnow·Wall Street's wire, on your screen.
ADVM· Adverum Biotechnologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADVM (Adverum Biotechnologies Inc.) and more on Quantisnow.